Skip to main content
. 2022 Mar 15;12:4451. doi: 10.1038/s41598-022-08595-1

Figure 4.

Figure 4

Treatment pathway of each choline esterase inhibitor (AChEI) group combined with NMDA receptor antagonist from all hospitals. For each choline esterase inhibitor group, Donepezil (A), rivastigmine (B), galantamine (C) and Group prescribed drugs at least 6 months later from initial diagnosis (D), the inner circle shows the first medication that the patient took, the second circle revealed the second medication.